Siga Technologies Overview
- Founded
-
1995

- Status
-
Public
- Employees
-
39

- Stock Symbol
-
SIGA

- Share Price
-
$23.30
- (As of Friday Closing)
Siga Technologies General Information
Description
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox.
Contact Information
Website
www.siga.com
Formerly Known As
Siga Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 31 East 62nd Street
- New York, NY 10065
- United States
+1 (212) 000-0000
Siga Technologies Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$23.30 | $19.47 | $5.84 - $23.87 | $1.7B | 73M | 16.1M | $0.95 |
Siga Technologies Financials Summary
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 685,696 | 465,032 | 484,473 | 387,953 |
Revenue | 147,410 | 133,670 | 124,959 | 26,742 |
EBITDA | 92,531 | 89,834 | 77,055 | 6,118 |
Net Income | 71,770 | 69,451 | 56,342 | (7,241) |
Total Assets | 159,940 | 214,727 | 149,831 | 198,566 |
Total Debt | 507 | 467 | 450 | 80,465 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Siga Technologies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Siga Technologies Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's
Pharmaceuticals
New York, NY
39
As of 2021
0000
000000000
0000
Siga Technologies Competitors (13)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Boehringer Ingelheim | Corporation | Ingelheim am Rhein, Germany | 00000 | |||
00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00.00 | 00000000000 | 00.00 |
000000 00000000 | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000000 | 00.000 |
00000000 | Corporation | Austin, TX | 00 | 0000 | 00000000 | 0000 |
Siga Technologies Patents
Siga Technologies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-1046277-A | Improvements to acetylene generators | Expired | 11-Dec-1951 | 000000000 |
Siga Technologies Executive Team (10)
Siga Technologies Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000 00.0 | Self | Board Member | 000 0000 |
00000 00000000 | Siga Technologies | Board Member | 000 0000 |
000000 000000 | Siga Technologies | Board Member | 000 0000 |
0000000 0000000 00 | Self | Board Member | 000 0000 |
000000 00000000 000 | Self | Board Member | 000 0000 |
Siga Technologies Signals
Siga Technologies Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|